Accessibility Log In Help Join The Motley Fool

Stratec Se (ETR: SBS)

€40.15

(-3.3%)

-€1.35

Price as of April 25, 2024, 11:30 a.m. ET

Stratec Se Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
SBS	-33.06%	-33.06%	-7.71%	+928%
S&P	+24.56%	+72.51%	+11.52%	+413%

Stratec Se Company Info

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.